Digoxin is still useful, but is still causing toxicity.

IF 3.4 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Cleveland Clinic Journal of Medicine Pub Date : 2024-08-01 DOI:10.3949/ccjm.91a.23105
Alejandro Durán Crane, Michael Militello, Michael D Faulx
{"title":"Digoxin is still useful, but is still causing toxicity.","authors":"Alejandro Durán Crane, Michael Militello, Michael D Faulx","doi":"10.3949/ccjm.91a.23105","DOIUrl":null,"url":null,"abstract":"<p><p>Digoxin, the oldest known cardiovascular drug, is still used today to treat heart failure and atrial fibrillation. Because it has a narrow therapeutic index and multiple interactions, it frequently causes toxicity with a wide range of symptoms and cardiac arrhythmias. More importantly, elevated serum digoxin levels have been linked to a higher risk of death in patients with heart failure or atrial fibrillation, even without signs or symptoms of toxicity. This article reviews the current state of digoxin use, its pharmacologic principles, and the mechanisms, clinical presentation, and management of toxicity.</p>","PeriodicalId":10245,"journal":{"name":"Cleveland Clinic Journal of Medicine","volume":null,"pages":null},"PeriodicalIF":3.4000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cleveland Clinic Journal of Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3949/ccjm.91a.23105","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Digoxin, the oldest known cardiovascular drug, is still used today to treat heart failure and atrial fibrillation. Because it has a narrow therapeutic index and multiple interactions, it frequently causes toxicity with a wide range of symptoms and cardiac arrhythmias. More importantly, elevated serum digoxin levels have been linked to a higher risk of death in patients with heart failure or atrial fibrillation, even without signs or symptoms of toxicity. This article reviews the current state of digoxin use, its pharmacologic principles, and the mechanisms, clinical presentation, and management of toxicity.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
地高辛仍然有用,但仍会引起中毒。
地高辛是已知最古老的心血管药物,如今仍被用于治疗心力衰竭和心房颤动。由于地高辛的治疗指数较窄,且存在多种相互作用,因此经常会引起中毒症状和心律失常。更重要的是,血清地高辛水平升高与心力衰竭或心房颤动患者的死亡风险升高有关,即使没有中毒症状或体征。本文回顾了地高辛的使用现状、药理原理以及中毒的机制、临床表现和处理方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Cleveland Clinic Journal of Medicine
Cleveland Clinic Journal of Medicine 医学-医学:内科
CiteScore
3.80
自引率
0.00%
发文量
109
审稿时长
6-12 weeks
期刊介绍: The mission of Cleveland Clinic Journal of Medicine (CCJM) is to provide its readers with up-to-date, practical, clinical information relevant to internal medicine, cardiology, and related fields. Consistent with this mission, CCJM focuses on timely review articles and other content that has a continuing-education orientation rather than on original research or case reports. CCJM authors, drawn from Cleveland Clinic and other top medical institutions throughout the world, are asked to identify new findings that are changing the practice of medicine and to advise readers how to apply them in daily patient care. Authors are chosen for their experience, acquired through caring for patients, teaching other physicians, and researching clinical questions.
期刊最新文献
A man with chronic limb-threatening ischemia and no revascularization options: Can we save his foot? Cervical cancer screening in high-risk patients: Clinical challenges in primary care. Effective but inaccessible antiobesity medications: A call for sharing responsibility for improving access to evidence-based care. It's time for a little history of medicine-introducing a new feature in CCJM. Primary adrenal insufficiency in adults.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1